Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2016 Jan 15;1862(4):778–787. doi: 10.1016/j.bbadis.2016.01.013

Figure 5.

Figure 5

Effect of rivastigmine treatment on protein expression of synaptic markers. Representative Western blots and densitometry analysis of pre-synaptic marker (SNAP-25), postsynaptic marker (PSD-95) and glutamate transporter 1 (GLT1) from brain homogenates of APP/mdr1+/+ (A), APP/mdr1+/− (B) and APP/mdr1−/− (C) mice following treatment with rivastigmine or vehicle. Data presented as mean±SEM (n = 3–6, * P<0.05, ** P<0.01, *** P<0.001 compared to vehicle-treated controls).